DIRECT BIOLOGICS LLC

In News

Direct Biologics Announces Significant Survival Benefit with ExoFlo™ in its Phase 2 Randomized Clinical Trial - bioinformant.com

bioinformant.com - Jul 13, 2023

Direct Biologics’ Phase 1 Clinical Trial Seeks to Treat Crohn Disease With Extracellular Vesicles - CGTLive®

CGTLive® - Dec 04, 2023

Rapid Micro Biosystems Receives Multi-System Order from Samsung Biologics to Expand Growth Direct Platform for Microbial Quality Control Automation - Quiver Quantitative

Quiver Quantitative - Mar 12, 2026

ADMA Biologics (ADMA) CEO exercises options and sells 21K shares - Stock Titan

Stock Titan - Mar 17, 2026

Direct Biologics Announces New Advanced Tool in Regenerative Medicine with Launch of AmnioWrap™ Placental Allograft - Newswire.com

Newswire.com - Jan 12, 2021

Alphyn Closes $25M Oversubscribed Series B Financing Round to Advance Dermatology Pipeline - PR Newswire

PR Newswire - Dec 12, 2025

Houston-based SPAC Good Works II aims to take Austin-based Direct Biologics public - The Business Journals

The Business Journals - Sep 29, 2022

Direct Biologics - The Pharma Letter

The Pharma Letter - Jun 30, 2024

Direct Biologics Receives FDA Approval to Initiate ‘EXIT COVID-19,’ a Phase II Investigational New Drug Trial with ExoFlo™ - bioinformant.com

bioinformant.com - Aug 02, 2020

For Nascent Exosome Field, One Company’s Win Is Everyone’s Gain - Citeline News & Insights

Citeline News & Insights - Sep 30, 2024

APEX Biologix, LLC Announces Agreement With New Exosome Supplier - Newswire.com

Newswire.com - Sep 19, 2019

ADMA Biologics (ADMA) director adds 12,500 shares in open-market buy - Stock Titan

Stock Titan - May 12, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment